article thumbnail

FDA Approves Prefilled Syringe Presentation for Shingles Vaccine

Drugs.com

MONDAY, July 21, 2025 -- The U.S. Food and Drug Administration has approved a prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of shingles (herpes zoster). The existing vaccine consists of two.

article thumbnail

Updated COVID Vaccines Effective Against New Strains

Drugs.com

THURSDAY, June 26, 2025 — Updated COVID-19 vaccines are keeping up with new coronavirus strains and remain effective for keeping people out of the hospital, a new study says. The study, which examined the effectiveness of the 2023-2024 COVID.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

RFK Jr. Removes Entire CDC Vaccine Advisory Panel

Drugs.com

TUESDAY, June 10, 2025 — U.S. vaccine recommendations. Health and Human Services Secretary Robert F. Kennedy Jr. has removed all 17 members of the expert panel that makes U.S. Kennedy made the surprise announcement in an opinion piece.

article thumbnail

HHS, NIH Unveil Vaccine Initiative to Protect Against Future Pandemics

Drugs.com

FRIDAY, May 2, 2025 -- The U.S. Department of Health and Human Services and the National Institutes of Health announced a new initiative called "Generation Gold Standard" to develop next-generation, universal vaccines using a beta-propiolactone.

article thumbnail

Moderna's New Lower-Dose COVID-19 Vaccine, mNexspike, Approved by FDA

Drugs.com

TUESDAY, June 3, 2025 -- The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2. The new vaccine (mNexspike [COVID-19 Vaccine.

article thumbnail

2025 Merkin Prize in Biomedical Technology awarded to pioneers of CAR T-cell therapy

Broad Institute

All nominations for the 2025 Merkin Prize were evaluated by a selection committee composed of nine scientific leaders from academia and industry in the US and Europe. The winners will be honored in a prize ceremony later this year.

article thumbnail

Q&A: One scientist’s bold vision to make on-demand treatments routine for life-threatening rare genetic diseases

Broad Institute

By Broad Communications June 24, 2025 Credit: Casey Atkins David Liu is a core member at the Broad Institute where he is the Richard Merkin Professor and director of the Merkin Institute for Transformative Technologies in Healthcare. s mutation and may never be used to treat another person.